These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20088327)

  • 21. Changes in opioid use and healthcare costs among U.S. patients with diabetic peripheral neuropathic pain treated with duloxetine compared with other therapies.
    Zhao Y; Wu N; Chen S; Boulanger L; Police RL; Fraser K
    Curr Med Res Opin; 2010 Sep; 26(9):2147-56. PubMed ID: 20662557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain.
    Raskin J; Smith TR; Wong K; Pritchett YL; D'Souza DN; Iyengar S; Wernicke JF
    J Palliat Med; 2006 Feb; 9(1):29-40. PubMed ID: 16430342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonin and noradrenaline involvement in urinary incontinence, depression and pain: scientific basis for overlapping clinical efficacy from a single drug, duloxetine.
    Thor KB; Kirby M; Viktrup L
    Int J Clin Pract; 2007 Aug; 61(8):1349-55. PubMed ID: 17608681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Duloxetine (Cymbalta) for diabetic neuropathic pain.
    Med Lett Drugs Ther; 2005 Aug 15-29; 47(1215-1216):67-8. PubMed ID: 16103866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Dual acting reuptake inhibitors in the treatment of depression and pain].
    Hajak G
    Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S280-3. PubMed ID: 17139587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and tolerability of duloxetine, a novel dual reuptake inhibitor, in the treatment of major depressive disorder.
    Schatzberg AF
    J Clin Psychiatry; 2003; 64 Suppl 13():30-7. PubMed ID: 14552654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Duloxetine for male stress incontinence.
    Chapple CR
    Eur Urol; 2006 Jun; 49(6):958-60. PubMed ID: 16522351
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of duloxetine on painful physical symptoms associated with depression.
    Goldstein DJ; Lu Y; Detke MJ; Hudson J; Iyengar S; Demitrack MA
    Psychosomatics; 2004; 45(1):17-28. PubMed ID: 14709757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and tolerability of duloxetine treatment of diabetic peripheral neuropathic pain between patients with and without cardiovascular conditions.
    Wernicke JF; Prakash A; Kajdasz DK; Houston J
    J Diabetes Complications; 2009; 23(5):349-59. PubMed ID: 18768332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Duloxetine's role in the treatment of depression and associated painful physical symptoms.
    Wohlreich MM; Watkin JG; Gonzales JS
    J Clin Psychiatry; 2004 Jul; 65(7):1018-9. PubMed ID: 15291696
    [No Abstract]   [Full Text] [Related]  

  • 31. [Physical complaints can overlap mental symptoms. Diffuse pain? Think about depression!].
    MMW Fortschr Med; 2006 Jun; 148(23):62. PubMed ID: 16826743
    [No Abstract]   [Full Text] [Related]  

  • 32. Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials.
    Sultan A; Gaskell H; Derry S; Moore RA
    BMC Neurol; 2008 Aug; 8():29. PubMed ID: 18673529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Duloxetine: a new serotonin/noradrenaline reuptake inhibitor for the treatment of depression.
    Rabasseda X
    Drugs Today (Barc); 2004 Sep; 40(9):773-90. PubMed ID: 15538550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The development of new antidepressants: focus on duloxetine and escitalopram.
    Huffman JC; Perlis RH
    Harv Rev Psychiatry; 2003; 11(1):30-6. PubMed ID: 12866739
    [No Abstract]   [Full Text] [Related]  

  • 35. Anti-nociceptive effect of duloxetine in mouse model of diabetic neuropathic pain.
    Kuhad A; Bishnoi M; Chopra K
    Indian J Exp Biol; 2009 Mar; 47(3):193-7. PubMed ID: 19405385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duloxetine (cymbalta) for fibromyalgia.
    Med Lett Drugs Ther; 2008 Jul; 50(1291):57-8. PubMed ID: 18654110
    [No Abstract]   [Full Text] [Related]  

  • 37. Switching to duloxetine in selective serotonin reuptake inhibitor non- and partial-responders: effects on painful physical symptoms of depression.
    Perahia DG; Quail D; Desaiah D; Montejo AL; Schatzberg AF
    J Psychiatr Res; 2009 Feb; 43(5):512-8. PubMed ID: 18707693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Common pathways of depression and pain.
    Delgado PL
    J Clin Psychiatry; 2004; 65 Suppl 12():16-9. PubMed ID: 15315473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studies.
    Kajdasz DK; Iyengar S; Desaiah D; Backonja MM; Farrar JT; Fishbain DA; Jensen TS; Rowbotham MC; Sang CN; Ziegler D; McQuay HJ
    Clin Ther; 2007; 29 Suppl():2536-46. PubMed ID: 18164920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An evaluation of the cardiovascular safety profile of duloxetine: findings from 42 placebo-controlled studies.
    Wernicke J; Lledó A; Raskin J; Kajdasz DK; Wang F
    Drug Saf; 2007; 30(5):437-55. PubMed ID: 17472422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.